The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
If PUR has consolidated 10:1 then why has share price only opened at 878% increase instead of 1000% ?
I hope the deal goes through and I am voting for it. The BOD had been trying to sell LHD over 12 months ago and its performance and their actions since then clearly shows they have lost interest in it. I bought my LHD shares at 4p each and with the deal valuing them at .385:1 for PMG shares there is an arbitrage situation which gives the ask value of PMG shares at only 10.5p each against PMG's present ask value of 13p.
Going ex-div on 3 July. Fill your boots while you can!
A very positive RNS regarding contracts secured by CSG's aviation division particularly in the middle east market
Sweett Group, the property and infrastructure consultancy, is pleased to provide the following business update for its three main reporting regions. Dean Webster, Chief Executive Officer, said: "The Group recently reached a significant milestone, reporting an order book of over £100m, and I am pleased to report the constituents of this order book include project commissions from across a range of sectors and service areas. Some of these are repeat business from our existing client base, whilst others are new business, indicating an improving market share across the regions and sectors in which we operate. Whilst markets continue to be highly competitive, I am encouraged by our pipeline of projects."
Vernalis plc announced today that it has received a $2.5 million final payment under its drug discovery collaboration with Genentech, a member of the Roche Group (SIX: RO, ROG: OTCQX: RHHBY). The collaboration, which commenced in January 2012, aimed to discover novel small molecules against an undisclosed target utilising Vernalis' fragment and structure-based drug discovery platform. The $2.5 million final payment to Vernalis announced today is in addition to the $1.5 million milestone received under this collaboration and separately announced on 4th February 2013. Full financial terms have not been disclosed. Ian Garland, CEO of Vernalis, commented: "We are delighted to receive this further payment which endorses the success of our Research group's work in collaboration with Genentech."
At the annual general meeting of the Company held on 23 January 2013 a resolution was passed approving the reduction of the share premium account of the Company amounting to £65million, subject to the confirmation of the Isle of Man ("IOM") High Court (the "Order"). Redefine International is pleased to announce that the IOM High Court has now granted the Order approving the reduction and the Order has been registered with the IOM Companies Registry. The reduction has therefore become effective and an amount of £65 million has been transferred from the Company's share premium account to its distributable reserve and will provide further flexibility for the Company's financial structure.
Simon Thompson at IC has today tipped THG as one of his bargain shares for 2013. Already up 2.12p!
PAKISTAN LEGISLATES TO MAKE ALL DISPOSABLE PLASTIC PRODUCTS OXO-BIODEGRADABLE .... Michael Laurier, CEO of Symphony, said: "This legislation is an important step forward for Pakistan in protecting its cities, lands, waterways and coasts from the blight of plastic pollution, because it is not possible to collect or control all of the plastic, which would otherwise lie or float around in the environment for decades. The Government of Pakistan has not banned plastic altogether, as it is a low-cost material essential for everyday living, and for protecting food from damage and contamination. Although this legislation is important for Pakistan, it has much wider implications. The legislation prohibits not only the manufacture of conventional disposable plastic products in Pakistan, but also prevents them being imported into Pakistan. This means that all companies anywhere in the world exporting to Pakistan disposable plastic products made from or packaged in conventional or bio-based PE, or PP, or in PS must make and/or package them in future with oxo-biodegradable technology from a supplier registered with the Pakistan Government. We are bringing this to the urgent attention of our Distributors serving more than 90 countries around the world. We are anticipating substantially increased demand for d2w following the new legislation, and we are confident that our exclusive Distributors, Business Dynamics Ltd., will provide the necessary support services to the industry in Pakistan. A free testing service will be offered in Symphony's laboratories, and also in Pakistan using Symphony's unique d2detector. This is a sophisticated portable device which can tell within 60 seconds whether a plastic product is oxo-biodegradable and which additives it contains (see http://degradable.net/play-videos/20). One d2detector unit has been shipped to Pakistan, and orders for d2w have been received. With manufacturing facilities for d2w in five countries, Symphony is well placed to supply, service and support this very significant market."
This is no dead cat bounce. There is something going on when the share price doubles over the last 5 days.
Further to the announcement made on 7 January 2013, the Board of Directors of the Company is pleased to announce the indicative timetable relating to the distribution of 6 pence per ordinary share (approximately £15 million) to be made to Shareholders. The distribution will be made via a B Share Scheme and will be subject to the indicative timetable set out below. TIMETABLE:- - Existing Ordinary Shares marked ex-entitlement to B Shares - 16 January 2013 - Record date for B shares - 18 January 2013 - Information circular and Form of Election sent to Shareholders - 18 January 2013 - B Shares issued (including crediting interim CREST entitlements) - 21 January 2013 - Election deadline for B Share Choices - 4 February 2013 - B Share Dividend Date and Purchase Date - 11 February 2013
Plaza Centers N.V, a leading emerging markets property developer, announces that it has received a written request from Elbit Ultrasound (Luxembourg) B.V./S.a.r.l, the Company's major shareholder, requesting to convene an Extraordinary General Meeting of the Company's shareholders ("EGM"). Accordingly, an EGM will take place on Monday 18 February 2013 at noon (CET), at the Park Plaza Victoria Hotel Amsterdam, Damrak 1-5, 1012, LG Amsterdam, the Netherlands. The sole item on the agenda is the proposed distribution to shareholders from the Company's free distributable reserves (vrij uitkeerbare reserves), in the total amount of EUR 30,015,800.